Search Results - "Olivier, Ken"

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models by Kamoun, Walid S., Kirpotin, Dmitri B., Huang, Zhaohua Richard, Tipparaju, Suresh K., Noble, Charles O., Hayes, Mark E., Luus, Lia, Koshkaryev, Alexander, Kim, Jaeyeon, Olivier, Ken, Kornaga, Tad, Oyama, Shinji, Askoxylakis, Vasileios, Pien, Christine, Kuesters, Geoffrey, Dumont, Nancy, Lugovskoy, Alexey A., Schihl, Sarah A., Wilton, John H., Geddie, Melissa L., Suchy, James, Grabow, Stephanie, Kohli, Neeraj, Reynolds, C. Patrick, Blaydes, Rachel, Zhou, Yu, Sawyer, Andrew J., Marks, James D., Drummond, Daryl C.

“…Antibody-mediated tumour targeting and nanoparticle-mediated encapsulation can reduce the toxicity of antitumour drugs and improve their efficacy. Here, we…”
Get full text

Dominant CD40 Receptor (CD40R) Antagonist Antibodies as Novel Approach to Treating Autoimmune Diseases by LaMontagne, Russell W, Olivier, Ken, Weaver, Bruce

“…The CD40R-CD40 ligand pathway is a key co-stimulatory pathway for driving T cell-dependent B cell activation and humoral immune responses. This pathway has…”
Get full text

Abstract 3912: MM-310, a novel EphA2-targeted docetaxel nanoliposome by Kirpotin, Dmitri B., Tipparaju, Suresh, Huang, Zhaohua Richard, Kamoun, Walid S., Pien, Christine, Kornaga, Tad, Oyama, Shinji, Olivier, Ken, Marks, James D., Koshkaryev, Alexander, Schihl, Sarah S., Fetterly, Gerald, Schoeberl, Birgit, Noble, Charles, Hayes, Mark, Drummond, Daryl C.

“…Taxanes are widely used to treat solid tumors either in the curative or palliative setting, in first or later lines of therapy. Analysis of docetaxel…”
Get full text

Abstract C90: HER2-targeted liposomal doxorubicin MM-302 has a favorable cardiosafety profile in preclinical models by Geretti, Elena, Reynolds, Joe, Hendriks, Bart, Eckelhofer, Isabelle, Espelin, Chris, Gaddy, Daniel, Klinz, Stephan, Lee, Helen, Leonard, Shannon, Olivier, Ken, Agresta, Sam, Niyikiza, Clet, Nielsen, Ulrik, Wickham, Thomas

“…Introduction: Anthracyclines have historically been the backbone of anticancer therapy for decades; however, the clinical observation of permanent…”
Get full text

Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity by CRITTENDEN, Marka, GOUGH, Michael, HARRINGTON, Kevin, OLIVIER, Ken, THOMPSON, Jill, VILE, Richard G

“…Expression of chemokines within tumors can be used to recruit immature dendritic cells (DCs) for the initiation of antitumor T-cell responses. Here, we…”
Get full text

SOCS-1 and SOCS-3 are Induced Early in Response to Mycobacteri a and Decrease Innate Immunity in vitro by Sampaio, Elizabeth Pereira, Zelazny, Adrian, Shea, Yvonne, Root, Jeremy, Paulson, Michele, Elloumi, Houda, Olivier, Ken, Holland, Steven

Get full text

Role of mechanical loading in intervertebral disc degeneration by Colliou, Olivier Ken

“…Recent studies suggest that typical intervertebral disc degeneration is a chronic biologic response to mechanical loading. However, very little is known about…”
Get full text

Role of mechanical loading in intervertebral disc degeneration by Colliou, Olivier Ken

“…Recent studies suggest that typical intervertebral disc degeneration is a chronic biologic response to mechanical loading. However, very little is known about…”
Get full text